ReP USP - Resultado da busca

Dissertação (Mestrado)
Avaliação individualizada do controle de qualidade tridimensional paciente específico para tratamentos de tumores cerebrais com IMRT (2024)
Silva, Jayane Julia Pereira da ; Pavoni, Juliana Fernandes (Orientador)
Unidade: FFCLRP
Subjects: NEOPLASIAS CEREBRAIS, NEOPLASIAS CEREBRAIS, DOSIMETRIA, QUALIDADE DO PROCESSO, QUALIDADE DO PRODUTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jayane Julia Pereira da. Avaliação individualizada do controle de qualidade tridimensional paciente específico para tratamentos de tumores cerebrais com IMRT. 2024. Dissertação (Mestrado) – Universidade de São Paulo, Ribeirão Preto, 2024. Disponível em: https://www.teses.usp.br/teses/disponiveis/59/59135/tde-04062024-141216/. Acesso em: 19 nov. 2024.
APA
Silva, J. J. P. da. (2024). Avaliação individualizada do controle de qualidade tridimensional paciente específico para tratamentos de tumores cerebrais com IMRT (Dissertação (Mestrado). Universidade de São Paulo, Ribeirão Preto. Recuperado de https://www.teses.usp.br/teses/disponiveis/59/59135/tde-04062024-141216/
NLM
Silva JJP da. Avaliação individualizada do controle de qualidade tridimensional paciente específico para tratamentos de tumores cerebrais com IMRT [Internet]. 2024 ;[citado 2024 nov. 19 ] Available from: https://www.teses.usp.br/teses/disponiveis/59/59135/tde-04062024-141216/
Vancouver
Silva JJP da. Avaliação individualizada do controle de qualidade tridimensional paciente específico para tratamentos de tumores cerebrais com IMRT [Internet]. 2024 ;[citado 2024 nov. 19 ] Available from: https://www.teses.usp.br/teses/disponiveis/59/59135/tde-04062024-141216/
Artigo de periodico
Human translesion DNA polymerases ι and κ mediate tolerance to temozolomide in MGMT-deficient glioblastoma cells (2024)
Latância, Marcela Teatin ; Leandro, Giovana da Silva ; Bastos, André Uchimura ; Moreno, Natália Cestari ; Ariwoola, Abu-Bakr Adetayo ; Martins, Davi Jardim ; Ashton, Nicholas William ; Ribeiro, Victoria Chaves ; Rocha, Clarissa Ribeiro Reily ; Woodgate, Roger ; Hoch, Nicolas Carlos ; Menck, Carlos Frederico Martins
Source: DNA Repair. Unidades: IQ, ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, NEOPLASIAS CEREBRAIS, GLIOMA, DNA POLIMERASES, QUIMIOTERAPIA, ANTINEOPLÁSICOS, DANO AO DNA, CÉLULAS CULTIVADAS DE TUMOR, CITOMETRIA DE FLUXO, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LATÂNCIA, Marcela Teatin et al. Human translesion DNA polymerases ι and κ mediate tolerance to temozolomide in MGMT-deficient glioblastoma cells. DNA Repair, v. 141, p. 13 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.dnarep.2024.103715. Acesso em: 19 nov. 2024.
APA
Latância, M. T., Leandro, G. da S., Bastos, A. U., Moreno, N. C., Ariwoola, A. -B. A., Martins, D. J., et al. (2024). Human translesion DNA polymerases ι and κ mediate tolerance to temozolomide in MGMT-deficient glioblastoma cells. DNA Repair, 141, 13 . doi:10.1016/j.dnarep.2024.103715
NLM
Latância MT, Leandro G da S, Bastos AU, Moreno NC, Ariwoola A-BA, Martins DJ, Ashton NW, Ribeiro VC, Rocha CRR, Woodgate R, Hoch NC, Menck CFM. Human translesion DNA polymerases ι and κ mediate tolerance to temozolomide in MGMT-deficient glioblastoma cells [Internet]. DNA Repair. 2024 ; 141 13 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.dnarep.2024.103715
Vancouver
Latância MT, Leandro G da S, Bastos AU, Moreno NC, Ariwoola A-BA, Martins DJ, Ashton NW, Ribeiro VC, Rocha CRR, Woodgate R, Hoch NC, Menck CFM. Human translesion DNA polymerases ι and κ mediate tolerance to temozolomide in MGMT-deficient glioblastoma cells [Internet]. DNA Repair. 2024 ; 141 13 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.dnarep.2024.103715
Trabalho de evento-resumo
Cell membrane-coated nanoparticles for improved glioblastoma treatment (2023)
Moreno, Natalia Sanchez ; Ferreira, Natália Noronha ; Galain, Isabel; Costa, Marta Sílvia Freitas da; Baltazar, Maria de Fátima Monginho; Zucolotto, Valtencir
Source: Program. Conference titles: Brazil MRS Meeting. Unidade: IFSC
Subjects: NANOCIÊNCIA, NANOTECNOLOGIA, NEOPLASIAS CEREBRAIS, MELATONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Natalia Sanchez et al. Cell membrane-coated nanoparticles for improved glioblastoma treatment. 2023, Anais.. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2023. Disponível em: https://repositorio.usp.br/directbitstream/79576bd0-c0a9-48e9-a91c-e5df9b0a00a1/3160925.pdf. Acesso em: 19 nov. 2024.
APA
Moreno, N. S., Ferreira, N. N., Galain, I., Costa, M. S. F. da, Baltazar, M. de F. M., & Zucolotto, V. (2023). Cell membrane-coated nanoparticles for improved glioblastoma treatment. In Program. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. Recuperado de https://repositorio.usp.br/directbitstream/79576bd0-c0a9-48e9-a91c-e5df9b0a00a1/3160925.pdf
NLM
Moreno NS, Ferreira NN, Galain I, Costa MSF da, Baltazar M de FM, Zucolotto V. Cell membrane-coated nanoparticles for improved glioblastoma treatment [Internet]. Program. 2023 ;[citado 2024 nov. 19 ] Available from: https://repositorio.usp.br/directbitstream/79576bd0-c0a9-48e9-a91c-e5df9b0a00a1/3160925.pdf
Vancouver
Moreno NS, Ferreira NN, Galain I, Costa MSF da, Baltazar M de FM, Zucolotto V. Cell membrane-coated nanoparticles for improved glioblastoma treatment [Internet]. Program. 2023 ;[citado 2024 nov. 19 ] Available from: https://repositorio.usp.br/directbitstream/79576bd0-c0a9-48e9-a91c-e5df9b0a00a1/3160925.pdf
Artigo de periodico
High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population (2023)
Moreno, Daniel Antunes; Bonatelli, Murilo; Antoniazzi, Augusto Perazzolo; Paula, Flávia Escremim de; Leal, Leticia Ferro; Garcia, Felipe Antônio de Oliveira; Paula, André Escremim de; Teixeira, Gustavo Ramos; Santana, Iara Viana Vidigal; Saggioro, Fabiano Pinto ; Neder, Luciano ; Valera, Elvis Terci ; Scrideli, Carlos Alberto ; Stavale, João; Malheiros, Suzana Maria Fleury; Lima, Matheus; Hajj, Glaucia Noeli Maroso; Garcia-Rivello, Hernan; Christiansen, Silvia; Nunes, Susana; Gil-da-Costa, Maria João; Pinheiro, Jorge; Martins, Flavia Delgado; Junior, Carlos Almeida; Mançano, Bruna Minniti; Reis, Rui Manuel
Source: Frontiers in Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, MEDULOBLASTOMA, HEREDITARIEDADE, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Daniel Antunes et al. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. Frontiers in Oncology, v. 13, 2023Tradução . . Disponível em: https://doi.org/10.3389/fonc.2023.1237170. Acesso em: 19 nov. 2024.
APA
Moreno, D. A., Bonatelli, M., Antoniazzi, A. P., Paula, F. E. de, Leal, L. F., Garcia, F. A. de O., et al. (2023). High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population. Frontiers in Oncology, 13. doi:10.3389/fonc.2023.1237170
NLM
Moreno DA, Bonatelli M, Antoniazzi AP, Paula FE de, Leal LF, Garcia FA de O, Paula AE de, Teixeira GR, Santana IVV, Saggioro FP, Neder L, Valera ET, Scrideli CA, Stavale J, Malheiros SMF, Lima M, Hajj GNM, Garcia-Rivello H, Christiansen S, Nunes S, Gil-da-Costa MJ, Pinheiro J, Martins FD, Junior CA, Mançano BM, Reis RM. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population [Internet]. Frontiers in Oncology. 2023 ;13[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fonc.2023.1237170
Vancouver
Moreno DA, Bonatelli M, Antoniazzi AP, Paula FE de, Leal LF, Garcia FA de O, Paula AE de, Teixeira GR, Santana IVV, Saggioro FP, Neder L, Valera ET, Scrideli CA, Stavale J, Malheiros SMF, Lima M, Hajj GNM, Garcia-Rivello H, Christiansen S, Nunes S, Gil-da-Costa MJ, Pinheiro J, Martins FD, Junior CA, Mançano BM, Reis RM. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population [Internet]. Frontiers in Oncology. 2023 ;13[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fonc.2023.1237170
Artigo de periodico
Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas (2023)
Sousa, Graziella Ribeiro de ; Salomão, Karina B.; Nagano, Luís Fernando Peinado ; Riemondy, Kent A.; Chagas, Pablo Shimaoka ; Veronez, Luciana Chain ; Saggioro, Fabiano Pinto ; Marie, Suely Kazue Nagahashi ; Yunes, José A.; Cardinalli, Izilda Aparecida; Brandalise, Silvia Regina ; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto ; Donson, Andrew M.; Foreman, Nicholas K.; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Cancer Gene Therapy. Unidades: FMRP, FM, FCFRP
Subjects: NEOPLASIAS CEREBRAIS, PERFILAÇÃO DA EXPRESSÃO GÊNICA, PROGNÓSTICO, FATORES DE TRANSCRIÇÃO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Graziella Ribeiro de et al. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer Gene Therapy, v. 30, p. 1105-1113, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41417-023-00616-z. Acesso em: 19 nov. 2024.
APA
Sousa, G. R. de, Salomão, K. B., Nagano, L. F. P., Riemondy, K. A., Chagas, P. S., Veronez, L. C., et al. (2023). Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer Gene Therapy, 30, 1105-1113. doi:10.1038/s41417-023-00616-z
NLM
Sousa GR de, Salomão KB, Nagano LFP, Riemondy KA, Chagas PS, Veronez LC, Saggioro FP, Marie SKN, Yunes JA, Cardinalli IA, Brandalise SR, Queiroz RG de P, Scrideli CA, Donson AM, Foreman NK, Tone LG, Valera ET. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas [Internet]. Cancer Gene Therapy. 2023 ; 30 1105-1113.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41417-023-00616-z
Vancouver
Sousa GR de, Salomão KB, Nagano LFP, Riemondy KA, Chagas PS, Veronez LC, Saggioro FP, Marie SKN, Yunes JA, Cardinalli IA, Brandalise SR, Queiroz RG de P, Scrideli CA, Donson AM, Foreman NK, Tone LG, Valera ET. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas [Internet]. Cancer Gene Therapy. 2023 ; 30 1105-1113.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41417-023-00616-z
Trabalho de evento-resumo
The rho gtpase pathway: a potential sensitizer of resistant glioblastoma (2023)
Magalhães, Yuli Thamires ; Boell, Viktor Kalbermatter ; Cardella, Giovanna Duó ; Forti, Fabio Luis
Source: Livro de Resumos. Conference titles: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology/SBBq. Unidade: IQ
Subjects: NEOPLASIAS CEREBRAIS, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHÃES, Yuli Thamires et al. The rho gtpase pathway: a potential sensitizer of resistant glioblastoma. 2023, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular, 2023. Disponível em: https://www2.sbbq.org.br/reuniao/images/livro_completo2023. Acesso em: 19 nov. 2024.
APA
Magalhães, Y. T., Boell, V. K., Cardella, G. D., & Forti, F. L. (2023). The rho gtpase pathway: a potential sensitizer of resistant glioblastoma. In Livro de Resumos. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular. Recuperado de https://www2.sbbq.org.br/reuniao/images/livro_completo2023
NLM
Magalhães YT, Boell VK, Cardella GD, Forti FL. The rho gtpase pathway: a potential sensitizer of resistant glioblastoma [Internet]. Livro de Resumos. 2023 ;[citado 2024 nov. 19 ] Available from: https://www2.sbbq.org.br/reuniao/images/livro_completo2023
Vancouver
Magalhães YT, Boell VK, Cardella GD, Forti FL. The rho gtpase pathway: a potential sensitizer of resistant glioblastoma [Internet]. Livro de Resumos. 2023 ;[citado 2024 nov. 19 ] Available from: https://www2.sbbq.org.br/reuniao/images/livro_completo2023
Artigo de periodico
Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial (2023)
Lepski, Guilherme ; Bergami-Santos, Patricia C. ; Pinho, Mariana P. ; Chauca-Torres, Nadia E. ; Evangelista, Gabriela C. M. ; Teixeira, Sarah F. ; Flatow, Elizabeth ; Oliveira, Jaqueline V. de ; Fogolin, Carla ; Peres, Nataly ; Arévalo, Analía ; Alves, Venâncio A. F. ; Barbuto, José Alexandre Marzagão
Source: Cancers. Unidades: FM, ICB
Subjects: IMUNOLOGIA, NEOPLASIAS CEREBRAIS, GLIOMA, IMUNOTERAPIA, ADJUVANTES IMUNOLÓGICOS, CÉLULAS DENDRÍTICAS, ASTROCITOMA, CÉLULAS CULTIVADAS DE TUMOR, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEPSKI, Guilherme et al. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, v. 15, n. 4, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15041239. Acesso em: 19 nov. 2024.
APA
Lepski, G., Bergami-Santos, P. C., Pinho, M. P., Chauca-Torres, N. E., Evangelista, G. C. M., Teixeira, S. F., et al. (2023). Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, 15( 4), 1-12. doi:10.3390/cancers15041239
NLM
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/cancers15041239
Vancouver
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/cancers15041239
Artigo de periodico
GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status (2023)
Moretti, Isabele Fattori ; Lerario, Antonio Marcondes ; Sola, Paula Rodrigues ; Silva, Janaína Macedo da; Baptista, Mauricio da Silva ; Palmisano, Giuseppe ; Shinjo, Sueli Mieko Oba ; Marie, Suely Kazue Nagahashi
Source: Cancers. Unidades: FM, IQ, ICB
Subjects: PARASITOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS CEREBRAIS, GLIOMA, LIPOPOLISSACARÍDEOS, ANTIOXIDANTES, ANTIDIABÉTICOS (HIPOGLICEMIANTES), ESTRESSE OXIDATIVO, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORETTI, Isabele Fattori et al. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status. Cancers, v. 15, n. 3, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15030587. Acesso em: 19 nov. 2024.
APA
Moretti, I. F., Lerario, A. M., Sola, P. R., Silva, J. M. da, Baptista, M. da S., Palmisano, G., et al. (2023). GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status. Cancers, 15( 3), 1-18. doi:10.3390/cancers15030587
NLM
Moretti IF, Lerario AM, Sola PR, Silva JM da, Baptista M da S, Palmisano G, Shinjo SMO, Marie SKN. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status [Internet]. Cancers. 2023 ; 15( 3): 1-18.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/cancers15030587
Vancouver
Moretti IF, Lerario AM, Sola PR, Silva JM da, Baptista M da S, Palmisano G, Shinjo SMO, Marie SKN. GBM cells Exhibit susceptibility to metformin treatment according to TLR4 pathway activation and metabolic and antioxidant status [Internet]. Cancers. 2023 ; 15( 3): 1-18.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/cancers15030587
Artigo de periodico
Characterization of glioblastoma spheroid models for drug screening and phototherapy assays (2023)
Alves, Samara Rodrigues ; Calori, Italo Rodrigo ; Bi, Hong; Tedesco, Antônio Cláudio
Source: OpenNano. Unidade: FFCLRP
Subjects: NEOPLASIAS CEREBRAIS, TERAPIA FOTODINÂMICA, GLIOMA, NANOPARTÍCULAS, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Samara Rodrigues et al. Characterization of glioblastoma spheroid models for drug screening and phototherapy assays. OpenNano, v. 9, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.onano.2022.100116. Acesso em: 19 nov. 2024.
APA
Alves, S. R., Calori, I. R., Bi, H., & Tedesco, A. C. (2023). Characterization of glioblastoma spheroid models for drug screening and phototherapy assays. OpenNano, 9, 1-11. doi:10.1016/j.onano.2022.100116
NLM
Alves SR, Calori IR, Bi H, Tedesco AC. Characterization of glioblastoma spheroid models for drug screening and phototherapy assays [Internet]. OpenNano. 2023 ; 9 1-11.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.onano.2022.100116
Vancouver
Alves SR, Calori IR, Bi H, Tedesco AC. Characterization of glioblastoma spheroid models for drug screening and phototherapy assays [Internet]. OpenNano. 2023 ; 9 1-11.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.onano.2022.100116
Trabalho de evento-resumo
Melatonin loaded polymeric nanoparticles for glioblastoma therapy (2023)
Moreno, Natalia Sanchez ; Silva, Iasmin Gabrielli da; Ferreira, Natália Noronha ; Zucolotto, Valtencir
Source: Program. Conference titles: Brazil MRS Meeting. Unidade: IFSC
Subjects: NANOCIÊNCIA, NANOTECNOLOGIA, NEOPLASIAS CEREBRAIS, MELATONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Natalia Sanchez et al. Melatonin loaded polymeric nanoparticles for glioblastoma therapy. 2023, Anais.. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2023. Disponível em: https://repositorio.usp.br/directbitstream/82a71893-6063-4dbb-a161-0f2d09173fa9/3160909.pdf. Acesso em: 19 nov. 2024.
APA
Moreno, N. S., Silva, I. G. da, Ferreira, N. N., & Zucolotto, V. (2023). Melatonin loaded polymeric nanoparticles for glioblastoma therapy. In Program. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. Recuperado de https://repositorio.usp.br/directbitstream/82a71893-6063-4dbb-a161-0f2d09173fa9/3160909.pdf
NLM
Moreno NS, Silva IG da, Ferreira NN, Zucolotto V. Melatonin loaded polymeric nanoparticles for glioblastoma therapy [Internet]. Program. 2023 ;[citado 2024 nov. 19 ] Available from: https://repositorio.usp.br/directbitstream/82a71893-6063-4dbb-a161-0f2d09173fa9/3160909.pdf
Vancouver
Moreno NS, Silva IG da, Ferreira NN, Zucolotto V. Melatonin loaded polymeric nanoparticles for glioblastoma therapy [Internet]. Program. 2023 ;[citado 2024 nov. 19 ] Available from: https://repositorio.usp.br/directbitstream/82a71893-6063-4dbb-a161-0f2d09173fa9/3160909.pdf
Artigo de periodico
Downregulation of the Rho GTPase pathway abrogates resistance to ionizing radiation in wild-type p53 glioblastoma by suppressing DNA repair mechanisms (2023)
Magalhães, Yuli Thamires ; Boell, Viktor Kalbermatter ; Cardella, Giovanna Duo; Forti, Fabio Luis
Source: Cell Death and Disease. Unidade: IQ
Subjects: NEOPLASIAS CEREBRAIS, RADIAÇÃO IONIZANTE, REPARAÇÃO DE DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGALHÃES, Yuli Thamires et al. Downregulation of the Rho GTPase pathway abrogates resistance to ionizing radiation in wild-type p53 glioblastoma by suppressing DNA repair mechanisms. Cell Death and Disease, v. 14, p. 1-16 art. 283, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41419-023-05812-1. Acesso em: 19 nov. 2024.
APA
Magalhães, Y. T., Boell, V. K., Cardella, G. D., & Forti, F. L. (2023). Downregulation of the Rho GTPase pathway abrogates resistance to ionizing radiation in wild-type p53 glioblastoma by suppressing DNA repair mechanisms. Cell Death and Disease, 14, 1-16 art. 283. doi:10.1038/s41419-023-05812-1
NLM
Magalhães YT, Boell VK, Cardella GD, Forti FL. Downregulation of the Rho GTPase pathway abrogates resistance to ionizing radiation in wild-type p53 glioblastoma by suppressing DNA repair mechanisms [Internet]. Cell Death and Disease. 2023 ; 14 1-16 art. 283.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41419-023-05812-1
Vancouver
Magalhães YT, Boell VK, Cardella GD, Forti FL. Downregulation of the Rho GTPase pathway abrogates resistance to ionizing radiation in wild-type p53 glioblastoma by suppressing DNA repair mechanisms [Internet]. Cell Death and Disease. 2023 ; 14 1-16 art. 283.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41419-023-05812-1
Artigo de periodico
Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence (2022)
Pinho, Mariana Pereira ; Lepski, Guilherme Alves; Rehder, Roberta ; Torres, Nadia Emely Chauca ; Evangelista, Gabriela Coeli Menezes ; Teixeira, Sarah Fernandes ; Flatow, Elizabeth Alexandra ; Oliveira, Jaqueline Vaz de ; Fogolin, Carla Sanzochi ; Bento, Nataly Peres Carvalho ; Arévalo, Analía Leonora ; Alves, Venâncio Avancini Ferreira ; Barbuto, José Alexandre Marzagão ; Santos, Patricia Cruz Bergami
Source: International Journal of Molecular Sciences. Unidades: FM, ICB
Subjects: IMUNOLOGIA, IMUNOTERAPIA, LINFÓCITOS T, NEOPLASIAS CEREBRAIS, VACINAS, CITOCINAS, IMUNOPROTEINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHO, Mariana Pereira et al. Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence. International Journal of Molecular Sciences, v. 23, n. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23105396. Acesso em: 19 nov. 2024.
APA
Pinho, M. P., Lepski, G. A., Rehder, R., Torres, N. E. C., Evangelista, G. C. M., Teixeira, S. F., et al. (2022). Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence. International Journal of Molecular Sciences, 23( 10), 1-10. doi:10.3390/ijms23105396
NLM
Pinho MP, Lepski GA, Rehder R, Torres NEC, Evangelista GCM, Teixeira SF, Flatow EA, Oliveira JV de, Fogolin CS, Bento NPC, Arévalo AL, Alves VAF, Barbuto JAM, Santos PCB. Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 10): 1-10.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/ijms23105396
Vancouver
Pinho MP, Lepski GA, Rehder R, Torres NEC, Evangelista GCM, Teixeira SF, Flatow EA, Oliveira JV de, Fogolin CS, Bento NPC, Arévalo AL, Alves VAF, Barbuto JAM, Santos PCB. Near-complete remission of Glioblastoma in a patient treated with an allogenic dendritic cell-based vaccine: the role of tumor-specific CD4+T-cell cytokine secretion pattern in predicting response and recurrence [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 10): 1-10.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/ijms23105396
Artigo de periodico
Extracellular vesicles throughout development: apotential roadmap for emerging glioblastoma therapies (2022)
Fernandes, Camila Felix de Lima ; Coelho, Bárbara Paranhos ; Souza, Maria Clara da Silva; Boccacino, Jacqueline Marcia ; Soares, Samuel Ribeiro; Araújo, João Pedro Alves de ; Escobar, Maria Isabel Melo ; Lopes, Marilene Hohmuth
Source: Seminars in Cell and Developmental Biology. Unidades: ICB, PRÓ-G
Subjects: BIOLOGIA CELULAR, EMBRIÃO, CÉLULAS-TRONCO, CÉLULAS CULTIVADAS DE TUMOR, GLIOMA, NEOPLASIAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Camila Felix de Lima et al. Extracellular vesicles throughout development: apotential roadmap for emerging glioblastoma therapies. Seminars in Cell and Developmental Biology, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.semcdb.2022.05.027. Acesso em: 19 nov. 2024.
APA
Fernandes, C. F. de L., Coelho, B. P., Souza, M. C. da S., Boccacino, J. M., Soares, S. R., Araújo, J. P. A. de, et al. (2022). Extracellular vesicles throughout development: apotential roadmap for emerging glioblastoma therapies. Seminars in Cell and Developmental Biology, 1-10. doi:10.1016/j.semcdb.2022.05.027
NLM
Fernandes CF de L, Coelho BP, Souza MC da S, Boccacino JM, Soares SR, Araújo JPA de, Escobar MIM, Lopes MH. Extracellular vesicles throughout development: apotential roadmap for emerging glioblastoma therapies [Internet]. Seminars in Cell and Developmental Biology. 2022 ; 1-10.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.semcdb.2022.05.027
Vancouver
Fernandes CF de L, Coelho BP, Souza MC da S, Boccacino JM, Soares SR, Araújo JPA de, Escobar MIM, Lopes MH. Extracellular vesicles throughout development: apotential roadmap for emerging glioblastoma therapies [Internet]. Seminars in Cell and Developmental Biology. 2022 ; 1-10.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.semcdb.2022.05.027
Artigo de periodico
DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide (2022)
Latancia, Marcela Teatin ; Moreno, Natália Cestari ; Leandro, Giovana da Silva ; Ribeiro, Victoria Chaves ; Souza, Izadora de; Vieira, William Kleber Martins; Bastos, André Uchimura ; Hoch, Nicolas Carlos ; Rocha, Clarissa Ribeiro Reily ; Menck, Carlos Frederico Martins
Source: Mutation Research - Genetic Toxicology and Environmental Mutagenesis. Unidades: IQ, ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, GLIOMA, NEOPLASIAS CEREBRAIS, DNA POLIMERASES, DANO AO DNA, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, MUTAGÊNESE, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LATANCIA, Marcela Teatin et al. DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide. Mutation Research - Genetic Toxicology and Environmental Mutagenesis, v. 878, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.mrgentox.2022.503498. Acesso em: 19 nov. 2024.
APA
Latancia, M. T., Moreno, N. C., Leandro, G. da S., Ribeiro, V. C., Souza, I. de, Vieira, W. K. M., et al. (2022). DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide. Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 878, 1-11. doi:10.1016/j.mrgentox.2022.503498
NLM
Latancia MT, Moreno NC, Leandro G da S, Ribeiro VC, Souza I de, Vieira WKM, Bastos AU, Hoch NC, Rocha CRR, Menck CFM. DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide [Internet]. Mutation Research - Genetic Toxicology and Environmental Mutagenesis. 2022 ; 878 1-11.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.mrgentox.2022.503498
Vancouver
Latancia MT, Moreno NC, Leandro G da S, Ribeiro VC, Souza I de, Vieira WKM, Bastos AU, Hoch NC, Rocha CRR, Menck CFM. DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide [Internet]. Mutation Research - Genetic Toxicology and Environmental Mutagenesis. 2022 ; 878 1-11.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.mrgentox.2022.503498
Artigo de periodico
NTRK2 gene fusions are uncommon in pilocytic astrocytoma (2022)
Moreno, Daniel Antunes; Becker, Aline Paixão; Scapulatempo-Neto, Cristovam; Menezes, Weder; Sheren, Jamie; Walter, Aline M; Clara, Carlos; Machado, Hélio Rubens ; Oliveira, Ricardo Santos de ; Neder, Luciano; Varella-Garcia, Marileila; Reis, Rui Manuel
Source: Molecular Biology Reports. Unidade: FMRP
Subjects: ASTROCITOMA, NEOPLASIAS CEREBRAIS, GLIOMA, HIBRIDIZAÇÃO, PROTEÍNAS PROTO-ONCOGÊNICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Daniel Antunes et al. NTRK2 gene fusions are uncommon in pilocytic astrocytoma. Molecular Biology Reports, v. 49, p. 7567-7573, 2022Tradução . . Disponível em: https://doi.org/10.1007/s11033-022-07567-y. Acesso em: 19 nov. 2024.
APA
Moreno, D. A., Becker, A. P., Scapulatempo-Neto, C., Menezes, W., Sheren, J., Walter, A. M., et al. (2022). NTRK2 gene fusions are uncommon in pilocytic astrocytoma. Molecular Biology Reports, 49, 7567-7573. doi:10.1007/s11033-022-07567-y
NLM
Moreno DA, Becker AP, Scapulatempo-Neto C, Menezes W, Sheren J, Walter AM, Clara C, Machado HR, Oliveira RS de, Neder L, Varella-Garcia M, Reis RM. NTRK2 gene fusions are uncommon in pilocytic astrocytoma [Internet]. Molecular Biology Reports. 2022 ; 49 7567-7573.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s11033-022-07567-y
Vancouver
Moreno DA, Becker AP, Scapulatempo-Neto C, Menezes W, Sheren J, Walter AM, Clara C, Machado HR, Oliveira RS de, Neder L, Varella-Garcia M, Reis RM. NTRK2 gene fusions are uncommon in pilocytic astrocytoma [Internet]. Molecular Biology Reports. 2022 ; 49 7567-7573.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s11033-022-07567-y
Artigo de periodico
Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity (2022)
Rodrigues Junior, Dorival Mendes ; Raminelli, Cristiano ; Hassanie, Haifa ; Trossini, Gustavo Henrique Goulart ; Perecim, Givago Prado; Puigsubira, Laia Caja ; Moustakas, Aristidis ; Vettore, André Luiz
Source: Scientific Reports. Unidade: FCF
Subjects: NEOPLASIAS CEREBRAIS, QUIMIOTERAPIA, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES JUNIOR, Dorival Mendes et al. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity. Scientific Reports, v. 12, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-25534-2. Acesso em: 19 nov. 2024.
APA
Rodrigues Junior, D. M., Raminelli, C., Hassanie, H., Trossini, G. H. G., Perecim, G. P., Puigsubira, L. C., et al. (2022). Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity. Scientific Reports, 12, 1-17. doi:10.1038/s41598-022-25534-2
NLM
Rodrigues Junior DM, Raminelli C, Hassanie H, Trossini GHG, Perecim GP, Puigsubira LC, Moustakas A, Vettore AL. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41598-022-25534-2
Vancouver
Rodrigues Junior DM, Raminelli C, Hassanie H, Trossini GHG, Perecim GP, Puigsubira LC, Moustakas A, Vettore AL. Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity [Internet]. Scientific Reports. 2022 ; 12 1-17.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41598-022-25534-2
Artigo de periodico
The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle? (2022)
Silva, Lucas Henrique Rodrigues da ; Catharino, Luana Correia Croda; Silva, Viviane Jennifer da ; Evangelista, Gabriela Coeli Menezes ; Barbuto, José Alexandre Marzagão
Source: Biomedicines. Unidades: ICB, FCF, FM
Subjects: IMUNOLOGIA, GLIOMA, NEOPLASIAS CEREBRAIS, CÉLULAS CULTIVADAS DE TUMOR, CITOTOXICIDADE IMUNOLÓGICA, LINFÓCITOS, CITOCINAS, METÁSTASE LINFÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Lucas Henrique Rodrigues da et al. The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle?. Biomedicines, v. 10, n. 2, p. 1-41, 2022Tradução . . Disponível em: https://doi.org/10.3390/biomedicines10020400. Acesso em: 19 nov. 2024.
APA
Silva, L. H. R. da, Catharino, L. C. C., Silva, V. J. da, Evangelista, G. C. M., & Barbuto, J. A. M. (2022). The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle? Biomedicines, 10( 2), 1-41. doi:10.3390/biomedicines10020400
NLM
Silva LHR da, Catharino LCC, Silva VJ da, Evangelista GCM, Barbuto JAM. The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle? [Internet]. Biomedicines. 2022 ; 10( 2): 1-41.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/biomedicines10020400
Vancouver
Silva LHR da, Catharino LCC, Silva VJ da, Evangelista GCM, Barbuto JAM. The war is on: the Immune System against Glioblastoma—how can NK cells drive this battle? [Internet]. Biomedicines. 2022 ; 10( 2): 1-41.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/biomedicines10020400
Artigo de periodico
Mathematical model of brain tumour growth with drug resistance (2021)
Trobia, José; Tian, Kun; Batista, Antonio ; Grebogi, Celso; Ren, Hai-Peng; Santos, Moises S.; Protachevicz, R. P. ; Borges, Fernando S.; Szezech, Jose Danilo ; Viana, Ricardo L.; Caldas, Iberê Luiz ; Iarosz, Kelly C.
Source: Communications in Nonlinear Science and Numerical Simulation. Unidade: IF
Subjects: FÍSICA MATEMÁTICA, BIOFÍSICA, GLIOMA, QUIMIOTERAPIA, NEOPLASIAS CEREBRAIS, EQUAÇÕES DIFERENCIAIS DA FÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROBIA, José et al. Mathematical model of brain tumour growth with drug resistance. Communications in Nonlinear Science and Numerical Simulation, v. 103, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.cnsns.2021.106013. Acesso em: 19 nov. 2024.
APA
Trobia, J., Tian, K., Batista, A., Grebogi, C., Ren, H. -P., Santos, M. S., et al. (2021). Mathematical model of brain tumour growth with drug resistance. Communications in Nonlinear Science and Numerical Simulation, 103. doi:10.1016/j.cnsns.2021.106013
NLM
Trobia J, Tian K, Batista A, Grebogi C, Ren H-P, Santos MS, Protachevicz RP, Borges FS, Szezech JD, Viana RL, Caldas IL, Iarosz KC. Mathematical model of brain tumour growth with drug resistance [Internet]. Communications in Nonlinear Science and Numerical Simulation. 2021 ; 103[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cnsns.2021.106013
Vancouver
Trobia J, Tian K, Batista A, Grebogi C, Ren H-P, Santos MS, Protachevicz RP, Borges FS, Szezech JD, Viana RL, Caldas IL, Iarosz KC. Mathematical model of brain tumour growth with drug resistance [Internet]. Communications in Nonlinear Science and Numerical Simulation. 2021 ; 103[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cnsns.2021.106013
Artigo de periodico
Expression profiling of glioblastoma cell lines reveals novel extracellular matrix-receptor genes correlated with the responsiveness of glioma patients to ionizing radiation (2021)
Serafim, Rodolfo Bortolozo; Silva, Patrick da; Cardoso, Cibele; Di Cristofaro, Luis Fernando Macedo; Netto, Renato Petitto; Almeida, Rodrigo de; Navegante, Geovana; Storti, Camila Baldin; Sousa, Juliana Ferreira de; Souza, Felipe Canto de; Panepucci, Rodrigo Alexandre; Moreira, Cristiano Gallina; Penna, Larissa Siqueira; Silva Junior, Wilson Araújo da ; Valente, Valéria
Source: Frontiers in Oncology. Unidade: FMRP
Subjects: RECEPTORES, PERFILAÇÃO DA EXPRESSÃO GÊNICA, MATRIZ EXTRACELULAR, NEOPLASIAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERAFIM, Rodolfo Bortolozo et al. Expression profiling of glioblastoma cell lines reveals novel extracellular matrix-receptor genes correlated with the responsiveness of glioma patients to ionizing radiation. Frontiers in Oncology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.668090. Acesso em: 19 nov. 2024.
APA
Serafim, R. B., Silva, P. da, Cardoso, C., Di Cristofaro, L. F. M., Netto, R. P., Almeida, R. de, et al. (2021). Expression profiling of glioblastoma cell lines reveals novel extracellular matrix-receptor genes correlated with the responsiveness of glioma patients to ionizing radiation. Frontiers in Oncology, 11. doi:10.3389/fonc.2021.668090
NLM
Serafim RB, Silva P da, Cardoso C, Di Cristofaro LFM, Netto RP, Almeida R de, Navegante G, Storti CB, Sousa JF de, Souza FC de, Panepucci RA, Moreira CG, Penna LS, Silva Junior WA da, Valente V. Expression profiling of glioblastoma cell lines reveals novel extracellular matrix-receptor genes correlated with the responsiveness of glioma patients to ionizing radiation [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fonc.2021.668090
Vancouver
Serafim RB, Silva P da, Cardoso C, Di Cristofaro LFM, Netto RP, Almeida R de, Navegante G, Storti CB, Sousa JF de, Souza FC de, Panepucci RA, Moreira CG, Penna LS, Silva Junior WA da, Valente V. Expression profiling of glioblastoma cell lines reveals novel extracellular matrix-receptor genes correlated with the responsiveness of glioma patients to ionizing radiation [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fonc.2021.668090
Artigo de periodico
Extracellular matrix proteome remodeling in human Glioblastoma and Medulloblastoma (2021)
Lima, Marina Trombetta ; Fernandes, Livia Rosa ; Pascale, Claudia Blanes Angeli ; Moretti, Isabele Fattori ; Franco, Yollanda Edwirges Moreira ; Mousessian, Adaliana Sorg ; Wakamatsu, Alda ; Lerario, Antonio M. ; Shinjo, Sueli Mieko Oba ; Pasqualucci, Carlos Augusto ; Marie, Suely Kazue Nagahashi ; Palmisano, Giuseppe
Source: Journal of Proteome Research. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MATRIZ EXTRACELULAR, GLIOMA, NEOPLASIAS CEREBRAIS, MEDULOBLASTOMA, PROTEÔMICA, ESPECTROMETRIA DE MASSAS, SISTEMA NERVOSO CENTRAL, GLICOPROTEÍNAS, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Marina Trombetta et al. Extracellular matrix proteome remodeling in human Glioblastoma and Medulloblastoma. Journal of Proteome Research, v. 20, p. 4693−4707, 2021Tradução . . Disponível em: https://doi.org/10.1021/acs.jproteome.1c00251. Acesso em: 19 nov. 2024.
APA
Lima, M. T., Fernandes, L. R., Pascale, C. B. A., Moretti, I. F., Franco, Y. E. M., Mousessian, A. S., et al. (2021). Extracellular matrix proteome remodeling in human Glioblastoma and Medulloblastoma. Journal of Proteome Research, 20, 4693−4707. doi:10.1021/acs.jproteome.1c00251
NLM
Lima MT, Fernandes LR, Pascale CBA, Moretti IF, Franco YEM, Mousessian AS, Wakamatsu A, Lerario AM, Shinjo SMO, Pasqualucci CA, Marie SKN, Palmisano G. Extracellular matrix proteome remodeling in human Glioblastoma and Medulloblastoma [Internet]. Journal of Proteome Research. 2021 ; 20 4693−4707.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1021/acs.jproteome.1c00251
Vancouver
Lima MT, Fernandes LR, Pascale CBA, Moretti IF, Franco YEM, Mousessian AS, Wakamatsu A, Lerario AM, Shinjo SMO, Pasqualucci CA, Marie SKN, Palmisano G. Extracellular matrix proteome remodeling in human Glioblastoma and Medulloblastoma [Internet]. Journal of Proteome Research. 2021 ; 20 4693−4707.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1021/acs.jproteome.1c00251

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration